As a young boy growing up in Nigeria, Hogan Bassey was tired of battling mosquitoes and malaria. At ten years old, a determined Hogan mixed up a home brew of household chemicals in the family bathtub in hopes of stopping mosquitoes and malaria for good. Although his homemade concoction fell short of his goal, Hogan never gave up his dream of helping people escape the discomfort and sometimes deadly diseases that come from insect bites. As a graduate of the University of Georgia, world traveler and Atlanta-area businessman, Hogan founded LivFul, Inc., a company that pioneers safe, innovative and accessible solutions to health issues around the world.
Matt Elsberry is an explorer and adventurer who loves working and interacting with people from different cultural backgrounds. After helping a nonprofit expand from 3 to 80 countries in six years, Matt decided to dedicate his life to blurring the line between mission and business. He and his wife spent five years in Jakarta, Indonesia, building the kingdom of God while they increased the Bumi Raya Group’s profitability through their three listed companies and several private ones. He sees his work at LivFul as a shining example of how a company can build the kingdom while building a profitable business.
LivFul is a biotech company on a mission to save 200,000 lives per year from mosquito and bacterial borne diseases. Their tagline is “saving lives and transforming communities.” Through their patented, plant-based, micro-encapsulation technology platform they are able to deliver superior products. LivFul’s first product, AKIVA, is a biodegradable insect repellent that lasts over 16 hours, feels invisible and has a gentle scent. Their platform technology allows them to deliver nature-based repellents that are 2-3x more effective than anything else on the market. LivFul has been working closely with Merck KGaA, who is aggressively pursuing a partnership.